Intracerebral haemorrhage

The Lancet

Volumn 373, Issue 9675, 2009, Pages 1632-1644

  Qureshi, Adnan I ^a   Mendelow, A David ^b   Hanley, Daniel F ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; DISUFENTON SODIUM; FIBRINOLYTIC AGENT; MANNITOL; PLACEBO; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP;

BLOOD CLOT; BLOOD PRESSURE REGULATION; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISABILITY; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; HYDROCEPHALUS; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MINIMALLY INVASIVE SURGERY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; SEIZURE;

EID: 65449176475     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60371-8     Document Type: Review

References (150)

1. Qureshi A.I., Tuhrim S., Broderick J.P., Batjer H.H., Hondo H., and Hanley D.F. Spontaneous intracerebral hemorrhage. N Engl J Med 344 (2001) 1450-1460
2. Labovitz D.L., Halim A., Boden-Albala B., Hauser W.A., and Sacco R.L. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and hispanics. Neurology 65 (2005) 518-522
3. Sudlow C.L., and Warlow C.P. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 28 (1997) 491-499
4. American Heart Organization. International cardiovascular disease statistics: cardiovascular disease (CVD). http://www.americanheart.org/downloadable/heart/1140811583642InternationalCVD.pdf (accessed Nov 21, 2007).
5. Qureshi A.I., Suri M.F.K., Nasar A., et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke 38 (2007) 2180-2184
6. Feigin V.L., Lawes C.M.M., Bennett D.A., and Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2 (2003) 43-53
7. Morgenstern L.B., and Spears W.D. A triethnic comparison of intracerebral hemorrhage mortality in Texas. Ann Neurol 42 (1997) 919-923
8. Kubo M., Kiyohara Y., Kato I., et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 34 (2003) 2349-2354
9. Jiang B., Wang W.Z., Chen H., et al. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke 37 (2006) 63-68
10. Rothwell P.M., Coull A.J., Giles M.F., et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363 (2004) 1925-1933
11. Steiner T., Rosand J., and Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke 37 (2006) 256-262
12. Takebayashi S., and Kaneko M. Electron microscopic studies of ruptured arteries in hypertensive intracerebral hemorrhage. Stroke 14 (1983) 28-36
13. Mizutani T., Kojima H., and Miki Y. Arterial dissections of penetrating cerebral arteries causing hypertension-induced cerebral hemorrhage. J Neurosurg 93 (2000) 859-862
14. Rosand J., Hylek E.M., O'Donnell H.C., and Greenberg S.M. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55 (2000) 947-951
15. Rost N.S., Greenberg S.M., and Rosand J. The genetic architecture of intracerebral hemorrhage. Stroke 39 (2008) 2166-2173
16. Hart R.G. What causes intracerebral hemorrhage during warfarin therapy?. Neurology 55 (2000) 907-908
17. Smith E.E., Gurol M.E., Eng J.A., et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 63 (2004) 1606-1612
18. Qureshi A.I., Suri M.F., Ostrow P.T., et al. Apoptosis as a form of cell death in intracerebral hemorrhage. Neurosurgery 52 (2003) 1041-1047
19. Qureshi A.I., Ali Z., Suri M.F., et al. Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. Crit Care Med 31 (2003) 1482-1489
20. Lusardi T.A., Wolf J.A., Putt M.E., Smith D.H., and Meaney D.F. Effect of acute calcium influx after mechanical stretch injury in vitro on the viability of hippocampal neurons. J Neurotrauma 21 (2004) 61-72
21. Graham D.I., McIntosh T.K., Maxwell W.L., and Nicoll J.A. Recent advances in neurotrauma. J Neuropathol Exp Neurol 59 (2000) 641-651
22. Nakamura T., Xi G., Park J.W., Hua Y., Hoff J.T., and Keep R.F. Holo-transferrin and thrombin can interact to cause brain damage. Stroke 36 (2005) 348-352
23. Xi G., Keep R.F., and Hoff J.T. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 5 (2006) 53-63
24. Nakamura T., Keep R.F., Hua Y., Nagao S., Hoff J.T., and Xi G. Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. Acta Neurochir Suppl 96 (2006) 194-248
25. Wagner K.R., Packard B.A., Hall C.L., et al. Protein oxidation and heme oxygenase-1 induction in porcine white matter following intracerebral infusions of whole blood or plasma. Dev Neurosci 24 (2002) 154-160
26. Wang J., and Tsirka S.E. Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 36 (2005) 613-648
27. Alvarez-Sabin J., Delgado P., Abilleira S., et al. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 35 (2004) 1316-1322
28. Aronowski J., and Hall C.E. New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol Res 27 (2005) 268-279
29. Hua Y., Wu J., Keep R.F., Nakamura T., Hoff J.T., and Xi G. Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery 58 (2006) 542-550
30. Gong C., Boulis N., Qian J., Turner D.E., Hoff J.T., and Keep R.F. Intracerebral hemorrhage-induced neuronal death. Neurosurgery 48 (2001) 875-882
31. Matz P.G., Lewen A., and Chan P.H. Neuronal, but not microglial, accumulation of extravasated serum proteins after intracerebral hemolysate exposure is accompanied by cytochrome c release and DNA fragmentation. J Cereb Blood Flow Metab 21 (2001) 921-928
32. Yang S., Nakamura T., Hua Y., et al. The role of complement C3 in intracerebral hemorrhage-induced brain injury. J Cereb Blood Flow Metab 26 (2006) 1490-1495
33. Fujii Y., Takeuchi S., Harada A., Abe H., Sasaki O., and Tanaka R. Hemostatic activation in spontaneous intracerebral hemorrhage. Stroke 32 (2001) 883-890
34. Broderick J.P., Diringer M.N., Hill M.D., et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 38 (2007) 1072-1075
35. Davis S.M., Broderick J., Hennerici M., et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66 (2006) 1175-1181
36. Qureshi A.I., Harris-Lane P., Kirmani J.F., et al. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med 34 (2006) 1975-1980
37. Kazui S.M.K., Sawada T., and Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 28 (1997) 2370-2375
38. Gebel Jr. J.M., Jauch E.C., Brott T.G., et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33 (2002) 2631-2635
39. Inaji M., Tomita H., Tone O., Tamaki M., Suzuki R., and Ohno K. Chronological changes of perihematomal edema of human intracerebral hematoma. Acta Neurochir Suppl 86 (2003) 445-448
40. Butcher K.S., Baird T., MacGregor L., Desmond P., Tress B., and Davis S. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 35 (2004) 1879-1885
41. Gebel Jr. J.M., Jauch E.C., Brott T.G., et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33 (2002) 2636-2641
42. Qureshi A.I., Hanel R.A., Kirmani J.F., Yahia A.M., and Hopkins L.N. Cerebral blood flow changes associated with intracerebral hemorrhage. Neurosurg Clin N Am 13 (2002) 355-370
43. Siddique M.S., Fernandes H.M., Wooldridge T.D., Fenwick J.D., Slomka P., and Mendelow A.D. Reversible ischemia around intracerebral hemorrhage: a single-photon emission computerized tomography study. J Neurosurg 96 (2002) 736-741
44. Kim-Han J.S., Kopp S.J., Dugan L.L., and Diringer M.N. Perihematomal mitochondrial dysfunction after intracerebral hemorrhage. Stroke 37 (2006) 2457-2462
45. Carhuapoma J.R., Wang P.Y., Beauchamp N.J., Keyl P.M., Hanley D.F., and Barker P.B. Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke 31 (2000) 726-732
46. Zazulia A.R., Diringer M.N., Videen T.O., et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 21 (2001) 804-810
47. Schellinger P.D., Fiebach J.B., Hoffmann K., et al. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra?. Stroke 34 (2003) 1674-1679
48. Orakcioglu B., Fiebach J.B., Steiner T., et al. Evolution of early perihemorrhagic changes-ischemia vs edema: an MRI study in rats. Exp Neurol 193 (2005) 369-376
49. Qureshi A.I., Wilson D.A., Hanley D.F., and Traystman R.J. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology 52 (1999) 266-272
50. Fiebach J.B., Schellinger P.D., Gass A., et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 35 (2004) 502-506
51. Kidwell C.S., Chalela J.A., Saver J.L., et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292 (2004) 1823-1830
52. Becker K.J., Baxter A.B., Bybee H.M., Tirschwell D.L., Abouelsaad T., and Cohen W.A. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 30 (1999) 2025-2032
53. Goldstein J.N., Fazen L.E., Snider R., et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology 68 (2007) 889-894
54. Steiner T., Katse M., Forsting M., et al. Recommendations for the management of intracranial haemorrhage-part I: spontaneous intracerebral haemorrhage. Cerebrovasc Dis 22 (2006) 294-316
55. Broderick J.P., Adams Jr. H.P., Barsan W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30 (1999) 905-915
56. Moon J.-S., Janjua N., Ahmed S., et al. Prehospital neurologic deterioration in patients with intracerebral hemorrhage. Crit Care Med 36 (2008) 172-175
57. Leira R., Davalos A., Silva Y., et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63 (2004) 461-467
58. Mayer S.A., Sacco R.L., Shi T., and Mohr J.P. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology 44 (1994) 1379-1384
59. Hemphill III J.C., Bonovich D.C., Besmertis L., Manley G.T., and Johnston S.C. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32 (2001) 891-897
60. Weimar C., Weber C., Wagner M., et al. Management patterns and health care use after intracerebral hemorrhage. a cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis 15 (2003) 29-36
61. Flaherty M.L., Haverbusch M., Sekar P., et al. Long-term mortality after intracerebral hemorrhage. Neurology 66 (2006) 1182-1186
62. Fogelholm R., Murros K., Rissanen A., and Avikainen S. Long term survival after primary intracerebral haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry 76 (2005) 1534-1538
63. Bailey R.D., Hart R.G., Benavente O., and Pearce L.A. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 56 (2001) 773-777
64. Chen Y.W., Gurol M.E., Rosand J., et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 67 (2006) 83-87
65. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
66. Hachinski V. Vascular behavioral and cognitive disorders. Stroke 34 (2003) 2775
67. Zurasky J.A., Aiyagari V., Zazulia A.R., Shackelford A., and Diringer M.N. Early mortality following spontaneous intracerebral hemorrhage. Neurology 64 (2005) 725-727
68. Hemphill III J.C., Newman J., Zhao S., and Johnston S.C. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke 35 (2004) 1130-1134
69. Diringer M.N., and Edwards D.F. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 29 (2001) 635-640
70. Mendelow A.D., Gregson B.A., Fernandes H.M., et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365 (2005) 387-397
71. Mayer S.A., Brun N.C., Begtrup K., et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358 (2008) 2127-2137
72. Tuhrim S. Intracerebral hemorrhage-improving outcome by reducing volume?. N Engl J Med 358 (2008) 2174-2176
73. Qureshi A.I., Mohammad Y.M., Yahia A.M., et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med 20 (2005) 34-42
74. Qureshi A.I., Geocadin R.G., Suarez J.I., and Ulatowski J.A. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med 28 (2000) 1556-1564
75. Goldstein J.N., Thomas S.H., Frontiero V., et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 37 (2006) 151-155
76. Gujjar A.R., Deibert E., Manno E.M., Duff S., and Diringer M.N. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 51 (1998) 447-451
77. Naff N.J., and Tuhrim S. Intraventricular hemorrhage in adults: complications and treatment. New Horizons 5 (1997) 359-363
78. Naff N.J., Carhuapoma J.R., Williams M.A., et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 31 (2000) 841-847
79. Naff N.J., Hanley D.F., Keyl P.M., et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 54 (2004) 577-583
80. Qureshi A.I., Safdar K., Weil J., et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 26 (1995) 1764-1767
81. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 777-785
82. Mayer S.A., Davis S.M., Begtrup K., et al. Subgroup analysis in the FAST trial: a subset of intracerebral hemorrhage patients that benefit from recombinant activated factor VII. Stroke 39 (2008) 528
83. Fernandes H.M., Siddique S., Banister K., et al. Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. Acta Neurochir Suppl 76 (2000) 463-466
84. Misra U.K., Kalita J., Ranjan P., and Mandal S.K. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci 234 (2005) 41-45
85. Kalita J., Misra U.K., Ranjan P., Pradhan P.K., and Das B.K. Effect of mannitol on regional cerebral blood flow in patients with intracerebral hemorrhage. J Neurol Sci 224 (2004) 19-22
86. Sansing L.H., Kaznatcheeva E.A., Perkins C.J., Komaroff E., Gutman F.B., and Newman G.C. Edema after intracerebral hemorrhage: correlations with coagulation parameters and treatment. J Neurosurg 98 (2003) 985-992
87. Dziedzic T., Szczudlik A., Klimkowicz A., Rog T.M., and Slowik A. Is mannitol safe for patients with intracerebral hemorrhages? Renal considerations. Clin Neurol Neurosurg 105 (2003) 87-89
88. Broderick J., Connolly S., Feldmann E., et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 38 (2007) 2001-2023
89. Qureshi A.I. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 118 (2008) 176-187
90. Qureshi A.I., Ezzeddine M.A., Nasar A., et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 25 (2007) 32-38
91. Ohwaki K., Yano E., Nagashima H., Hirata M., Nakagomi T., and Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 35 (2004) 1364-1367
92. Qureshi A.I. Antihypertensive treatment of acute cerebral hemorrhage (ATACH): rationale and design. Neurocrit Care 6 (2007) 56-66
93. Anderson C.S., Huang Y., Wang G., et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a pilot randomised trial. Lancet Neurol 7 (2008) 391-399
94. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) trial: International Stroke Conference. New Orleans, LA; Feb 20-22, 2008.
95. Bhattathiri P.S., Gregson B., Prasad K.S., and Mendelow A.D. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl 96 (2006) 65-68
96. Ohwaki K., Yano E., Nagashima H., Hirata M., Nakagomi T., and Tamura A. Surgery for patients with severe supratentorial intracerebral hemorrhage. Neurocrit Care 5 (2006) 15-20
97. Hanley D.F. Intraventricular hemorrhage and ICH outcomes: severity factor and treatment target. Stroke (2009) published online Feb 26. 10.1161/STROKEAHA.108.535419 (accessed March 12, 2009).
98. Yilmazlar S., Abas F., and Korfali E. Comparison of ventricular drainage in poor grade patients after intracranial hemorrhage. Neurol Res 27 (2005) 653-656
99. Huttner H.B., Nagel S., Tognoni E., et al. Intracerebral hemorrhage with severe ventricular involvement: lumbar drainage for communicating hydrocephalus. Stroke 38 (2007) 183-187
100. Steiner T., Diringer M.N., Schneider D., et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 59 (2006) 767-773
101. Huttner H.B., Tognoni E., Bardutzky J., et al. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol 15 (2008) 342-349
102. Andrews C.O., and Engelhard H.H. Fibrinolytic therapy in intraventricular hemorrhage. Ann Pharmacother 35 (2001) 1435-1448
103. Nieuwkamp D.J., de Gans K., Rinkel G.J., and Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 247 (2000) 117-121
104. Nyquist P., and Hanley D.F. The use of intraventricular thrombolytics in intraventricular hemorrhage. J Neurol Sci 261 (2007) 84-88
105. Zhang Z., Li X., Liu Y., Shao Y., Xu S., and Yang Y. Application of neuroendoscopy in the treatment of intraventricular hemorrhage. Cerebrovasc Dis 24 (2007) 91-96
106. Longatti P.L., Martinuzzi A., Fiorindi A., Maistrello L., and Carteri A. Neuroendoscopic management of intraventricular hemorrhage. Stroke 35 (2004) e35-e38
107. Yadav Y.R., Mukerji G., Shenoy R., Basoor A., Jain G., and Nelson A. Endoscopic management of hypertensive intraventricular haemorrhage with obstructive hydrocephalus. BMC Neurol 7 (2007) 1
108. Mendelow A.D., and Unterberg A. Surgical treatment of intracerebral haemorrhage. Curr Opin Crit Care 13 (2007) 169-174
109. Teernstra O.P., Evers S.M., Lodder J., Leffers P., Franke C.L., and Blaauw G. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34 (2003) 968-974
110. Auer L.M., Deinsberger W., Niederkorn K., et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 70 (1989) 530-535
111. Rabinstein A.A., Atkinson J.L., and Wijdicks E. Emergency craniotomy in patients worsening due to expanded cerebral hematoma: to what purpose?. Neurology 58 (2002) 1367-1372
112. Pantazis G., Tsitsopoulos P., Mihas C., Katsiva V., Stavrianos V., and Zymaris S. Early surgical treatment vs conservative management for spontaneous supratentorial intracerebral hematomas: a prospective randomized study. Surg Neurol 66 (2006) 492-501
113. Broderick J.P. The STICH trial: what does it tell us and where do we go from here?. Stroke 36 (2005) 1619-1620
114. Hattori N., Katayama Y., Maya Y., and Gatherer A. Impact of stereotactic hematoma evacuation on activities of daily living during the chronic period following spontaneous putaminal hemorrhage: a randomized study. J Neurosurg 101 (2004) 417-420
115. Morgenstern L.B., Demchuk A.M., Kim D.H., Frankowski R.F., and Grotta J.C. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 56 (2001) 1294-1299
116. Wang C.X., and Shuaib A. Neuroprotective effects of free radical scavengers in stroke. Drugs Aging 24 (2007) 537-546
117. Lyden P.D., Shuaib A., Lees K.R., et al. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke 38 (2007) 2262-2269
118. Morioka J., Fujii M., Kato S., et al. Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy. Surg Neurol 65 (2006) 67-72
119. Wijdicks E.F., St Louis E.K., Atkinson J.D., and Li H. Clinician's biases toward surgery in cerebellar hematomas: an analysis of decision-making in 94 patients. Cerebrovasc Dis 10 (2000) 93-96
120. Kirollos R.W., Tyagi A.K., Ross S.A., van Hille P.T., and Marks P.V. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery 49 (2001) 1378-1386
121. Yamamoto T., Nakao Y., Mori K., and Maeda M. Endoscopic hematoma evacuation for hypertensive cerebellar hemorrhage. Minim Invasive Neurosurg 49 (2006) 173-178
122. St Louis E.K., Wijdicks E.F., and Li H. Predicting neurologic deterioration in patients with cerebellar hematomas. Neurology 51 (1998) 1364-1369
123. Sumer M.M., Acikgoz B., and Akpinar G. External ventricular drainage for acute obstructive hydrocephalus developing following spontaneous intracerebral haemorrhages. Neurol Sci 23 (2002) 29-33
124. Passero S., Rocchi R., Rossi S., Ulivelli M., and Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 43 (2002) 1175-1180
125. Vespa P.M., O'Phelan K., Shah M., et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 60 (2003) 1441-1446
126. Claassen J., Mayer S.A., Kowalski R.G., Emerson R.G., and Hirsch L.J. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 62 (2004) 1743-1748
127. Misra U.K., Kalita J., Pandey S., Mandal S.K., and Srivastava M. A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. J Neurol Sci 239 (2005) 5-10
128. Ogata T., Yasaka M., Wakugawa Y., Inoue T., Ibayashi S., and Okada Y. Deep venous thrombosis after acute intracerebral hemorrhage. J Neurol Sci 272 (2008) 83-86
129. Christensen M.C., Dawson J., and Vincent C. Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity. Adv Ther 25 (2008) 831-841
130. Lacut K., Bressollette L., Le Gal G., et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65 (2005) 865-869
131. Albers G.W., Amarenco P., Easton J.D., Sacco R.L., and Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 suppl (2004) 483S-512S
132. Boeer A., Voth E., Henze T., and Prange H.W. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 54 (1991) 466-467
133. Kelly J., Hunt B.J., Lewis R.R., and Rudd A. Anticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism?. Stroke 34 (2003) 2999-3005
134. Huttner H.B., Kohrmann M., Berger C., Georgiadis D., and Schwab S. Predictive factors for tracheostomy in neurocritical care patients with spontaneous supratentorial hemorrhage. Cerebrovasc Dis 21 (2006) 159-165
135. Flaherty M.L., Kissela B., Woo D., et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68 (2007) 116-121
136. Palareti G., Leali N., Coccheri S., et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 48 (1996) 23-28
137. Rosand J., Hylek E.M., O'Donnell H.C., and Greenberg S.M. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55 (2000) 947-951
138. Sjoblom L., Hardemark H.G., Lindgren A., et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 32 (2001) 2567-2574
139. Flibotte J.J., Hagan N., O'Donnell J., Greenberg S.M., and Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63 (2004) 1059-1064
140. Yasaka M., Minematsu K., Naritomi H., Sakata T., and Yamaguchi T. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 89 (2003) 278-283
141. Huttner H.B., Schellinger P.D., Hartmann M., et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 37 (2006) 1465-1470
142. Goldstein J.N., Thomas S.H., Frontiero V., et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 37 (2006) 151-155
143. Brody D.L., Aiyagari V., Shackleford A.M., and Diringer M.N. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2 (2005) 263-267
144. Roitberg B., Emechebe-Kennedy O., Amin-Hanjani S., Mucksavage J., and Tesoro E. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery 57 (2005) 832-836
145. Rabinstein A.A., and Wijdicks E. Determinants of outcome in anticoagulation-associated cerebral hematoma requiring emergency evacuation. Arch Neurol 64 (2007) 203-206
146. Eckman M.H., Rosand J., Knudsen K.A., Singer D.E., and Greenberg S.M. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 34 (2003) 1710-1716
147. Keir S.L., Wardlaw J.M., Sandercock P.A., and Chen Z. Antithrombotic therapy in patients with any form of intracranial haemorrhage: a systematic review of the available controlled studies. Cerebrovasc Dis 14 (2002) 197-206
148. Butler A.C., and Tait R.C. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol 103 (1998) 1064-1066
149. Phan T.G., Koh M., and Wijdicks E.F. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 57 (2000) 1710-1713
150. Anonymous. Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke 36 (2005) e23-e41